Thomas H. Lee Partners and Frazier Healthcare Partners Acquire Adare Pharmaceuticals

Adare Pharma Solutions Acquires Frontida BioPharm

December 1, 2021

Pharmaceuticals

Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.

Frazier Healthcare Partners Acquires EPTAM Precision Solutions

January 22, 2020

Manufacturing

Frazier Healthcare Partners acquired EPTAM Precision Solutions from New Heritage Capital in a transaction that closed in December 2019; terms were not disclosed. Frazier named Operating Partner Mark Kemp as CEO and plans to accelerate EPTAM's growth and expand its precision manufacturing capabilities for medical device and other high-precision end markets.

Frazier Healthcare Partners Acquires 50% Stake in CSafe Global from Thomas H. Lee Partners

January 6, 2021

Logistics & Distribution

Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners. CSafe, headquartered in Dayton, Ohio, is a provider of cold chain shipping solutions for pharmaceutical and life sciences customers; THL will remain a partner alongside Frazier to support the company's next phase of growth. Terms of the transaction were not disclosed.

ADVI Health Acquires Partnership for Health Analytic Research (PHAR)

August 23, 2024

Healthcare Services

ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.

Frazier Healthcare Partners Acquires BioMatrix Specialty Infusion Pharmacy

June 25, 2024

Healthcare Services

Frazier Healthcare Partners has completed the acquisition of BioMatrix Holdings, LLC (BioMatrix Specialty Infusion Pharmacy), a Plantation, Florida–based provider of home-based specialty infusion services. Financial terms were not disclosed; Frazier is partnering with industry executives Ted and Kathee Kramm to expand BioMatrix’s national footprint and accelerate growth through new locations and add-on acquisitions.

Ampersand Capital Partners Invests in Alliance Pharma

November 18, 2021

Healthcare Services

Ampersand Capital Partners has made a growth equity investment in Alliance Pharma, a Malvern, Pennsylvania–based bioanalytical CRO. The funding will support Alliance’s expansion of global reach, scientific capabilities, and operational capacity while founder Frank Li remains a significant shareholder.